{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:20:51Z","timestamp":1788265251953,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.vaccine.2008.03.010","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T12:11:07Z","timestamp":1207051867000},"page":"2772-2781","source":"Crossref","is-referenced-by-count":39,"title":["Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis"],"prefix":"10.1016","volume":"26","author":[{"given":"Tomohiro","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Widman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.03.010_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.1996.tb124960.x","article-title":"An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995","volume":"165","author":"Hanna","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2008.03.010_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2008.03.010_bib3","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2006.05.130","article-title":"Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004","volume":"25","author":"Nakayama","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.virusres.2006.05.004","article-title":"Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines","volume":"121","author":"Abe","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2008.03.010_bib6","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2006.12.046","article-title":"A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis","volume":"25","author":"Lyons","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib7","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00705-006-0822-z","article-title":"An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus","volume":"152","author":"Ge","year":"2007","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4142\/jvs.2005.6.2.125","article-title":"Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice","volume":"6","author":"Yang","year":"2005","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2008.03.010_bib10","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.vaccine.2003.12.008","article-title":"Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone","volume":"22","author":"Mutoh","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-4-17","article-title":"Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line","volume":"4","author":"Zhang","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2008.03.010_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.micinf.2005.05.023","article-title":"Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis","volume":"8","author":"Appaiahgari","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2008.03.010_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/hv.1.3.1797","article-title":"Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE in non-human primates","volume":"1","author":"Dean","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2008.03.010_bib15","first-page":"1043","article-title":"Flaviviruses","volume":"vol. 1","author":"Burke","year":"2001"},{"key":"10.1016\/j.vaccine.2008.03.010_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(08)60263-8","article-title":"Epitope mapping of flavivirus glycoproteins","volume":"31","author":"Heinz","year":"1986","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2008.03.010_bib17","first-page":"1","article-title":"Immune response to traditional and genetically engineered Japanese encephalitis vaccines","volume":"2","author":"Konishi","year":"2000","journal-title":"Recent Res Dev Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.03.010_bib19","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib20","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.010_bib21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine","volume":"101","author":"Kofler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.03.010_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.virol.2006.04.003","article-title":"Production and characterization of vaccines based on flaviviruses defective in replication","volume":"351","author":"Mason","year":"2006","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.vaccine.2008.03.010_bib23","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2008.03.009","article-title":"Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system","volume":"26","author":"Widman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib24","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1128\/JVI.79.12.7597-7608.2005","article-title":"Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells","volume":"79","author":"Petrakova","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2006.02.036","article-title":"Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines","volume":"351","author":"Fayzulin","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.03.010_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.03.010_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.virol.2006.11.026","article-title":"Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1","volume":"362","author":"Suzuki","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.03.010_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0042-6822(87)90207-8","article-title":"Partial nucleotide sequence of the Japanese encephalitis virus genome","volume":"158","author":"McAda","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.03.010_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.virol.2004.10.046","article-title":"Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action","volume":"331","author":"Rossi","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.03.010_bib30","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/CVI.00051-07","article-title":"Epitope-blocking enzyme-linked immunosorbent assay to differentiate West Nile virus from Japanese encephalitis virus infections in equine sera","volume":"14","author":"Kitai","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4269\/ajtmh.2004.71.639","article-title":"Construction of yellow fever\/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool","volume":"71","author":"Pugachev","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.03.010_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid0803.010238","article-title":"Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.010_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2008.03.010_bib34","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.03.010_bib35","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2006.06.008","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"24","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib36","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/JVI.79.9.5516-5528.2005","article-title":"Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys","volume":"79","author":"Blaney","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib37","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1128\/JVI.75.17.8259-8267.2001","article-title":"Tick-borne Langat\/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes","volume":"75","author":"Pletnev","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Yellow Fever Working Group. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib39","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2008.03.010_bib40","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib41","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.03.010_bib42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(97)00278-8","article-title":"Genetic variability among yellow fever virus 17D substrains","volume":"16","author":"Galler","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/JVI.74.1.24-32.2000","article-title":"Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage in vitro is lethal for virus production","volume":"74","author":"Lee","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib44","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1128\/JVI.73.10.8083-8094.1999","article-title":"Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing","volume":"73","author":"Amberg","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.78.1.178-186.2004","article-title":"Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes","volume":"78","author":"Lobigs","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","article-title":"Japanese encephalitis vaccine","volume":"30","author":"Oya","year":"1988","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2008.03.010_bib47","first-page":"337","article-title":"Japanese encephalitis vaccines","volume":"73","year":"1998","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2008.03.010_bib48","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1016\/S0264-410X(03)00507-3","article-title":"Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice","volume":"21","author":"Takasaki","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib49","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1016\/j.vaccine.2005.04.036","article-title":"The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus","volume":"23","author":"Yamshchikov","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.2002.66.115","article-title":"Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines","volume":"66","author":"Kanesa-Thasan","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.03.010_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JVI.72.1.191-200.1998","article-title":"DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice","volume":"72","author":"Lin","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2005.03.026","article-title":"A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model","volume":"112","author":"Volpina","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2008.03.010_bib53","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vaccine.2005.07.059","article-title":"Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence","volume":"24","author":"Costa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.010_bib55","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JVI.60.3.1153-1155.1986","article-title":"Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1","volume":"60","author":"Schlesinger","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.03.010_bib56","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1099\/vir.0.80120-0","article-title":"Fusion PCR generated Japanese encephalitis virus\/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice","volume":"85","author":"Mathenge","year":"2004","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T17:04:01Z","timestamp":1588525441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":56,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0264410X08003101"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}